Pancreatic Cancer

ECOG-ACRIN-EA2186

A Randomized Phase II Study of Gemcitabine and Nab- Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naive Metastatic Pancreatic Cancer (GIANT)

PI: Grant Williams, M.D.

ETCTN-10208

A Phase I study of Anetumab Ravtansine in Combination with either Anti-PD-1 Antibody, or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma

PI: Olumide Gbolahan, M.D.

UAB1926

Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response

PI: Harrison Kim, Ph.D.

ALLIANCE A021806

Randomized Phase III study comparing up front surgery to perioperative FOLFIRINOX of resectable pancreatic cancer

PI: J Bart Rose, M.D.

UAB1707

Phase I SG CD40

PI: Olumide Gbolahan, M.D.

UAB2039

Irinotecan liposome injection, oxaliplatin, 5FU / leucovorin vs. nab-paclitaxel + Gem in previously untreated metastatic adenocarcinoma of the pancreas

PI: Grant Williams, M.D.

UAB1830

Phase I Minnelide Capsules Stage IV

PI: Olumide Gbolahan, M.D.

Billiary

UAB1951

Pembro + gem/cis vs. placebo + gem/cis first line advanced or unresectable biliary tract carcinoma

PI: Olumide Gbolahan, M.D.

ETCTN10222

Phase II study of olaparib and AZD6738 in IDH mutant solid tumors

PI: Olumide Gbolahan, M.D.